This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: **The Innovative Contributions of Yoshimasa Ishida**
Introduction
Yoshimasa Ishida, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals. His expertise has led to the development of a notable patent focusing on therapeutic solutions for diseases linked to interleukin-6 (IL-6). By working with Chugai Seiyaku Kabushiki Kaisha, Ishida demonstrates how innovation can address critical health challenges.
Latest Patents
Ishida holds a patent for a "Composition for treating IL-6-related diseases." This pharmaceutical composition focuses on utilizing an IL-6 inhibitor as its active ingredient. The innovative aspect of this invention lies in its dosing protocol, which allows for administration after a short-interval dosing period, enhancing the effectiveness of the treatment.
Career Highlights
Throughout his career at Chugai Seiyaku Kabushiki Kaisha, Yoshimasa Ishida has been dedicated to advancing pharmaceutical research and development. His singular patent showcases his focus on developing solutions for significant health issues, particularly those related to inflammation and immune responses.
Collaborations
In his role at Chugai Seiyaku Kabushiki Kaisha, Ishida has collaborated with notable colleagues including Takahiro Kakehi and Akinori Yamada. Together, these professionals contribute to a dynamic research environment that fosters innovation and drives the discovery of novel therapeutic approaches.
Conclusion
Yoshimasa Ishida's work exemplifies the impact that dedicated inventors can have in the pharmaceutical industry. His patented formulation offers hope for better treatment options for IL-6-related diseases and illustrates the importance of collaboration in scientific advancements. Through his efforts, Ishida continues to pave the way for future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
